XOMA Corp (XOMA)

Currency in USD
25.49
-0.09(-0.35%)
Closed·
25.490.00(0.00%)
·
XOMA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
25.2225.83
52 wk Range
18.3539.92
Key Statistics
Prev. Close
25.58
Open
25.36
Day's Range
25.22-25.83
52 wk Range
18.35-39.92
Volume
72.77K
Average Volume (3m)
63.02K
1-Year Change
-4.24%
Book Value / Share
7.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
XOMA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
64.50
Upside
+153.04%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

XOMA Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

XOMA Company Profile

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Compare XOMA to Peers and Sector

Metrics to compare
XOMA
Peers
Sector
Relationship
P/E Ratio
32.0x−2.3x−0.6x
PEG Ratio
0.25−0.080.00
Price/Book
3.6x3.8x2.6x
Price / LTM Sales
6.7x9.6x3.2x
Upside (Analyst Target)
127.5%16.0%41.8%
Fair Value Upside
Unlock2.1%5.1%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 64.50
(+153.04% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Benchmark
Buy50.00+96.16%50.00Maintain12/12/2025
H.C. Wainwright
Buy97.00+280.54%104.00Maintain11/12/2025
Leerink Partners
Buy45.00+76.54%58.00Maintain11/12/2025
Lucid Capital Markets
Buy76.00+198.16%-New Coverage09/12/2025
Leerink Partners
Buy58.00+127.54%55.00Maintain13/11/2025

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
0.70 / -0.09
Revenue / Forecast
9.35M / 9.97M
EPS Revisions
Last 90 days

XOMA (XOMA) Income Statement & Profits

People Also Watch

11.29
OOMA
-1.22%
13.07
WBTN
-0.15%
29.22
KMT
0.00%
4.490
RLMD
0.00%
2.190
PRLD
-3.10%

FAQ

What Is the XOMA (XOMA) Share Price Today?

The live XOMA share price today is 25.49

What Stock Exchange Does XOMA (XOMA) Trade On?

XOMA is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for XOMA?

The stock symbol (also called a 'ticker') for XOMA is "XOMA."

What Is the Current XOMA Market Cap?

As of today, XOMA market capitalisation is 315.65M.

What Is XOMA's (XOMA) Earnings Per Share (TTM)?

The XOMA EPS is currently 0.82 (Trailing Twelve Months).

When Is the Next XOMA Earnings Date?

XOMA's next earnings report will be released on 05 Mar 2026.

Is XOMA a Buy or Sell From a Technical Analyst Perspective?

Based on today's XOMA moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has XOMA Stock Split?

XOMA has split 2 times. (See the XOMA stock split history page for full effective split date and price information.)

How Many Employees Does XOMA Have?

XOMA has 13 employees.

What is the current trading status of XOMA (XOMA)?

As of 24 Dec 2025, XOMA (XOMA) is trading at a price of 25.49, with a previous close of 25.58. The stock has fluctuated within a day range of 25.22 to 25.83, while its 52-week range spans from 18.35 to 39.92.

What Is XOMA (XOMA) Price Target According to Analysts?

The average 12-month price target for XOMA is USD64.5, with a high estimate of USD97 and a low estimate of USD45. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +153.04% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.